Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T22:05:59.293Z Has data issue: false hasContentIssue false

Cochleotoxicity due to Mianserin hydrochloride

Published online by Cambridge University Press:  29 June 2007

J. Marais*
Affiliation:
London
*
J. Marais, M.B., B.Ch., The Royal National Throat, Nose & Ear Hospital, Gray's Inn Road, London WC1X 8DA.

Abstract

A patient who developed bilateral tinnitus and symmetrical high frequency sensorineural hearing loss due to therapy with the anti-depressant Mianserin hydrochloride is presented together with a short review of available literature.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Martindale (1989) The Extra Pharmacopoiea. 29th edn. (Reynolds, J. E., ed). Pharmaceutical Press, London, p 372375.Google Scholar
Naylor, G. J., Martin, B. (1985) A double blind outpatient trial of Indalpine vs Mianserin. British Journal of Psychiatry, 147: 306309.CrossRefGoogle ScholarPubMed
Seppala, T., Stromberg, C., Bergman, I. (1984) Effects of Zimeldine, Zimeldine, Mianserin and Amitryptiline on psychomotor skills and their interactions with ethanol. A placebo-controlled cross-over study. European Journal of Clinical Pharmacology, 27(2): 181189.CrossRefGoogle Scholar